Revelation Biosciences, Inc — Form D
Revelation Biosciences, Inc of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-07-06. The offering totals $1.0M, of which $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-07-06
- Form: D
- Accession: 0001812479-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $1.0M
- Investors: 10
- Date of first sale: 2020-05-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-370302
Issuer
- Name: Revelation Biosciences, Inc
- CIK: 0001812479
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 4660 LAJOLLA VILLAGE DRIVE, SAN DIEGO, CA, 92122
- Phone: 650-800-3717
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Chester S Zygmont | Director | San Diego, CA |
| Chester S Zygmont III | Executive Officer | San Diego, CA |
| Jennifer F Carver | Director | San Diego, CA |
| Jess F Roper | Director | San Diego, CA |
| James M Rolke | Director | San Diego, CA |
| James M Rolke | Executive Officer | San Diego, CA |
| Curt F LaBelle | Director | San Diego, CA |
| George F Tidmarsh | Director | San Diego, CA |
| Chester S Zygmont | Executive Officer | San Diego, CA |
Other filings by this issuer (3)
More